echoloc

Integrated DNA Technologies Tech Stack

Genomics research platform and nucleic acid synthesis provider

Biotechnology Research Coralville, IA 1,001–5,000 employees Founded 1987 Privately Held

Integrated DNA Technologies manufactures oligonucleotides, genes, and synthesis reagents for genomic research and diagnostics—a capital-intensive, quality-critical operation reflected in their infrastructure stack (SAP ERP, LPLMS, qPCR, Illumina sequencing). The hiring mix (support-heavy, manufacturing-focused, with embedded healthcare and ops roles) and active projects (facility safety reviews, medical strategy, clinical evidence generation) signal a company in transition from pure manufacturing toward clinical applications and regulatory compliance, now accelerating hiring to scale production and support.

Tech Stack 30 technologies

Core StackPython Salesforce SAP Marketo Pandas Power BI Terraform AWS Grafana CloudWatch Kubernetes PostgreSQL LC-MS CRM qPCR Microsoft Project Oracle Primavera FMEA Illumina Nextflow Polars ClinVar CMMS LIMS SAP ERP HPLC Tecan BLAST AWS EKS Bash

What Integrated DNA Technologies Is Building

Challenges

  • Maintaining reliability of production deployments
  • Expanding support coverage
  • Clinical evidence generation
  • Identifying program gaps
  • Reducing eh&s risk
  • Reducing incidents
  • Improving safety performance
  • Reducing company costs
  • Innovation acceleration
  • Time to market reduction

Active Projects

  • Monitoring dashboards with grafana
  • Customer infrastructure deployment with terraform and aws
  • Automation scripting to reduce toil
  • Medical strategy development for product lifecycle
  • Post-marketing medical insights
  • Clinical evidence generation and communication
  • External eh&s audits
  • Global facility eh&s review process
  • Global eh&s sustainability strategy
  • Global initiatives to reduce incidents

Hiring Activity

Accelerating110 roles · 100 in 30d

Department

Support
26
Manufacturing
16
Ops
15
Research
10
Sales
10
Healthcare
9
Operations
6
Product
5

Seniority

Mid
41
Senior
33
Manager
23
Director
6
Junior
4
Principal
2
Lead
1
Company intelligence

Find more companies like Integrated DNA Technologies by tech stack, pain points and active projects

Get started free

About Integrated DNA Technologies

IDT, part of Danaher's life sciences division, manufactures custom oligonucleotides, genes, and synthesis reagents for genomic research. Founded in 1987 and based in Coralville, Iowa, the company has grown to 1,001–5,000 employees across facilities in the United States, Germany, Belgium, Japan, Australia, Singapore, and Canada. Core offerings include DNA and RNA synthesis, next-generation sequencing products (Illumina-compatible), and GMP-grade manufacturing. The business serves academic researchers, biotech firms, and clinical diagnostics providers. Operations rely on integrated lab automation (qPCR, HPLC, Tecan instruments), data infrastructure (SAP ERP, LIMS), and cloud deployment (AWS, Terraform, Kubernetes).

HeadquartersCoralville, IA
Company Size1,001–5,000 employees
Founded1987
Hiring MarketsUnited States, Germany, Belgium, Japan, Australia, Singapore, Canada

Frequently Asked Questions

What is Integrated DNA Technologies' tech stack?

IDT uses SAP ERP, Salesforce CRM, PostgreSQL, AWS/Kubernetes, Illumina sequencing, Nextflow (bioinformatics), Grafana (monitoring), Power BI (analytics), and lab instruments including LC-MS, HPLC, qPCR, and Tecan automation.

Where is Integrated DNA Technologies headquartered?

Coralville, Iowa. The company operates manufacturing and research facilities across the United States, Germany, Belgium, Japan, Australia, Singapore, and Canada.

How this profile is built

Integrated DNA Technologies's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.